Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R2NE
|
|||
| Former ID |
DCL000795
|
|||
| Drug Name |
Entacapone+levodopa+carbidopa
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0] | Phase 3 | [1] | |
| Restless legs syndrome [ICD-11: 7A80; ICD-10: G25.8] | Phase 3 | [1] | ||
| Company |
Orion; Novartis
|
|||
| SuperDrug ATC ID |
N04BX02
|
|||
| SuperDrug CAS ID |
cas=116314671
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective. Neuropsychiatr Dis Treat. 2008 February; 4(1): 39-47. | |||
| REF 2 | Emerging drugs for restless legs syndrome. Expert Opin Emerg Drugs. 2005 Aug;10(3):537-52. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.